MedPath

A comparative study of the therapeutic effect of topical finasteride with oral finasteride in patients with androgenetic alopecia .

Phase 3
Recruiting
Conditions
Androgenic alopecia.
Androgenic alopecia
Registration Number
IRCT20220901055844N1
Lead Sponsor
Shiraz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
28
Inclusion Criteria

Having androgenic alopecia grade 2 to 5 based on the Norwood Hamilton classification in men
Age above 18 years
Not receiving treatment for androgenic alopecia during the last 3 months
Having androgenetic alopecia grade 2 to 3 according to Ludwig grading in women
Menopausal women or women over 18 years of age who use IUD or TL.
Informed consent to participate in the study

Exclusion Criteria

Failure to sign the consent form.
History of allergic reaction and anaphylaxis to Finasteride drug
Pregnancy or trying to have a child.
Individual history of infertility
Active infection or any scratches and wounds in the scalp

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.